Mitsikostas, D. D. http://orcid.org/0000-0002-4691-3388
Alexoudi, A.
Arvaniti, C.
Giannouli, E.
Kouremenos, Ε.
Constantinidis, T. S.
Fakas, Ν.
Deligianni, C.
Karapanayiotides, T.
Dardiotis, Ε.
Gatzonis, S.
Konitsiotis, S.
Tsivgoulis, G.
,
Funding for this research was provided by:
NA
University of Athens
Article History
Accepted: 14 March 2023
First Online: 6 April 2023
Declarations
:
: Αpproval was not sought from any ethics committee because no data from patients were analyzed, while only a review of the relevant bibliography was performed.
: Not applicable.
: All authors have reviewed the final version and gave their approval for publication.
: Dimos D. Mitsikostas has received fees for lectures, travel, and research from AbbVie/Allergan, Amgen, Genesis Pharma, Eli Lilly, Lundbeck, Merz, Merck Serono, Novartis, Sanofi, and Teva. He has participated in clinical studies for migraine of Amgen, Eli Lilly, electroCore, Lundbeck, Novartis, and Teva. He is the president of the Hellenic Headache Society and co-chairman of the Headache Panel of the European Academy of Neurology.Chrysa Arvaniti has received fees for lectures, travel, and research from Eli Lilly, Novartis, and Teva.Athanasia Alexoudi has received fees for lectures, travel, and research from AbbVie/Allergan, Abbott, Eli Lilly, Teva, and Alzheimer’s Association.Ermioni Giannouli has received fees for lectures, travel, and advisory board participation from AbbVie/Allergan, Genesis Pharma, Eli Lilly, Merck Serono, Novartis, Sanofi, and Teva.Evangelos Kouremenos has received fees for lectures, travel, and research from AbbVie/Allergan, Genesis Pharma, Medicare, Merck, Novartis, Sanofi, Teva, and Viatris.Theodoros S. Constantinidis has received fees as honoraria for lectures, advisory boards, research and clinical trials, congress registration, and travel from Teva-Specifar, Novartis, Allergan-AbbVie, Elpen, UCB, Genesis Pharma-Biogen, Merck Serono, Sanofi-Genzyme, Bayer, Pharmathen, Arriani, Brain Therapeutics, and C.A. Papaellinas.Nikolaos Fakas has received speech honoraria, travel expenses, and consultation fees from AbbVie, Bristol Myers Squibb, Eli Lilly, Elpen, Genesis Pharma, Merck Serono, Novartis, Roche, Sanofi, and Teva. He has participated in clinical trials of Actelion, Amgen, Biogen, Celgene, Eli Lilly, Janssen, Merck, Novartis, Receptos, Roche, Sanofi, and Teva and received research support from Roche Diagnostics.Christina Deligianni has received the International Headache Society research fellowship grant for the year 2021, and she is a member of the European Headache Federation Board of Directors.Theodoros Karapanayiotides received fees for lectures, travel, research, and advisory boards from Bayer, Eli Lilly, Innovis, IPSEN, Novartis, Pfizer, and Teva.Efthimios Dardiotis has received fees for lectures, travel, and research from AbbVie/Allergan, Bayer, Genesis Pharma, Lundbeck, Merck Serono, Novartis, Sanofi, UCB, Teva, and Tikun.Stylianos Gatzonis has received fees as honoraria for lectures, advisory boards, research and clinical trials, congress registration, and travel from UCB, Tikun, Novartis, Sanofi, Lilly Pharmaserv, Pfizer, Genesis Pharma-Biogen, Glaxo-Wellcome, Sanofi-Genzyme, Ariani, Janssen-Cilag, Bayern, Merck Serono, Εlpen, Pharmathen, Teva-Specifar, Cyberonics, and Cormed.Spyros Konitsiotis has received fees for lectures, travel, consultation, and research from AbbVie, BMS, Genesis Pharma, Medison, Medtronic, Merck, Novartis, Teva, and UCB.Georgios Tsivgoulis is the president of the Hellenic Neurological Society and general secretary of the Hellenic Society of Cerebrovascular Diseases. He also serves as the vice-president of European Stroke Organization. He has received no funding or fees relevant to this publication.